Panel, Conference Presentation
Poised to Break the Bank: Paying for Chronic Disease
Milken InstituteAllison Aubrey, Nancy Brown, Thomas Davis, Anand Parekh, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
- Approximately two-thirds of all US healthcare expenditures are attributed to chronic, lifestyle-related diseases such as diabetes and obesity.
- Geisinger Health implemented a pilot "food pharmacy" program in central Pennsylvania, providing 150 participants with uncontrolled type 2 diabetes one year of fresh food, nutrition education, and one-on-one dietitian support.
- Participant outcomes in the Geisinger pilot included significant weight loss (e.g., one 56-year-old man lost 100 pounds) and revealed that patients often lack actionable instructions on weight management despite medical advice.
- Financial modeling from the Geisinger pilot indicates that for every one-point drop in hemoglobin A1c, healthcare costs decrease by approximately $8,000, though the program's long-term scalability remains under review.
- The 2018 Farm Bill allocated federal funding for food pharmacy pilots nationwide, signaling congressional support for these interventions, yet implementation has been limited by the lack of sufficient uptake.
- Experts emphasize matching the intensity of intervention to the acuity of the patient; Geisinger's high-intensity approach (meals twice daily, five days a week) was effective for high-risk individuals with food insecurity but difficult to replicate in highly mobile populations.
- Reimbursement structures significantly influence intervention success; capitated payment models incentivize prevention and lifestyle changes, whereas fee-for-service models often fail to cover non-clinical services like nutrition counseling.
- The Affordable Care Act designated nutrition counseling as an essential benefit, yet integration of these services into primary care remains low, with few patients receiving coordinated care with registered dietitians or community programs like the YMCA.
- Data fragmentation across approximately 200 sources (claims, pharmacy, consumer data) hinders the ability to deliver personalized, genotypically informed therapies for chronic diseases.
- Pharmaceutical incentives currently favor chronic therapies that generate recurring revenue, creating a misalignment with the goal of developing transformative, curative treatments like gene or cell therapies.
- The Diabetes Prevention Program (DPP) trials demonstrated that lifestyle interventions are more effective than metformin in halting the progression from prediabetes to type 2 diabetes, a model adapted by digital platforms like Omada Health and Livongo.
- Scaling digital prevention programs faces challenges regarding program integrity, fraud prevention, and sustaining long-term user engagement compared to clinical trials.
- The American Heart Association supports taxation on sugar-sweetened beverages as a policy lever to reduce youth consumption and address health disparities, citing successful precedents with tobacco and alcohol taxes.
- Bipartisan initiatives, such as recommendations from a SNAP task force, suggest excluding sugary drinks from federal nutrition assistance programs, though political opposition persists in some regions.
- A CEO Roundtable of 50 major US companies identified employee demand for mental health support, cost transparency, and technology-based wellness interventions, with 74% of employees reporting anxiety or depression.
- Mental health and physical health are deeply interconnected; unaddressed anxiety, depression, and loneliness are identified as critical barriers to adherence to lifestyle changes and management of chronic conditions.
- The opioid crisis coexists with a chronic pain epidemic, requiring a shift toward evidence-based non-pharmacological interventions (e.g., acupuncture, biofeedback, physical therapy) while maintaining careful, judicious opioid use for specific patient populations.
- HHS issued new guidelines correcting the interpretation of CDC guidelines to prevent rapid opioid tapering, acknowledging that abrupt cessation can lead to suicidal ideation and that 3–4 million patients still require long-term opioid therapy.
- A major barrier to chronic disease prevention is that 90% of the 83 million Americans with prediabetes are unaware of their status, highlighting a critical need for improved screening and awareness campaigns.
- Medical education currently provides insufficient training in nutrition, mental health, and pain management; Kaiser Permanente is launching a new medical school focused on prevention to address this curriculum gap.
- Multi-payer initiatives are proposed as a solution to the "churn" problem, where employers lose the financial benefit of preventive investments as employees change jobs; collective action can align incentives across public and private payers.
- Pain perception is described as a complex construct influenced by mindset and social context, making complete elimination of pain a potentially harmful goal; the objective is instead the "titration" of pain to a functional level.
- Behavioral economics suggests framing prevention as immediate health promotion and family well-being rather than future loss avoidance to improve engagement and participation in lifestyle interventions.